Patent · US Active

Anti-C-met antibody and methods of use thereof

US9150655B2 · kind B2 · utility

2Cited by
0References
16Claims
0Family size

Assignees

Inventors

Key dates

Filing dateAug 30, 2011
Grant dateOct 6, 2015
Priority date
Expiry dateFeb 23, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Antibodies that bind to c-Met are provided herein, as well as related compositions and methods of use. Methods of use encompass cancer therapies and diagnostics. In certain embodiments, antibodies bind mammalian cell surface antigen (e.g., cancer cell surface antigen). The antibodies can also be endocytosed upon binding to cells. Cells that can be targeted by the antibodies include carcinomas, such as those in lung, kidney, liver, stomach, breast, and brain, etc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.